세계 재택화학요법 서비스 시장 : 제품 유형별, 암 유형별, 국가별, 지역별- 산업 분석, 시장 규모, 시장 점유율 예측(2023-2030년)

REPORT HIGHLIGHT

Chemotherapy At Home Services Market size was valued at USD 1,508 Million in 2022, expanding at a CAGR of 8.5% from 2023 to 2030.

Chemotherapy treatment at home offers several potential advantages. Firstly, it eliminates the need for frequent travel to hospital facilities, saving patients time and energy. Additionally, there is a reduced risk of acquiring infections that are commonly associated with hospitals. By receiving treatment in the comfort and security of their own homes, patients can experience a greater sense of ease and familiarity. This also minimizes disruptions to family life, allowing patients to maintain a sense of normalcy during their treatment. Moreover, receiving chemotherapy at home can provide patients with a heightened sense of control over their treatment and illness. To ensure accurate and up-to-date information on available services and any changes in the delivery of chemotherapy treatments, it is crucial to consult with healthcare providers or contact local healthcare authorities. While home healthcare services may be available for certain aspects of cancer care, such as home health nursing, supportive care, or palliative care, it is important to note that the administration of chemotherapy drugs may still require a controlled medical setting.

Chemotherapy At Home Services Market- Market Dynamics

The growth of the Chemotherapy At Home Services market is expected to be driven by the increasing incidence of different types of cancer and the growing trend of patients transitioning from hospital to home care settings.

Many individuals express a preference for receiving medical care in the comfort of their own homes whenever possible. By providing healthcare services in a home-based setting, it can enhance patient convenience and alleviate the burden of frequent hospital visits. As the number of cancer cases continues to rise, healthcare facilities may face increased pressure and demand for their services. Home-based chemotherapy services can help alleviate some of this pressure by allowing patients to receive treatment in a non-hospital environment. According to the National Center for Health Statistics, it is projected that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. The advancement of medical technology, such as portable infusion pumps and remote monitoring devices, presents a growth opportunity for the chemotherapy at home services market. However, it is important to address safety concerns and consider the limited applicability of these services, as they may hinder the market's growth.

Chemotherapy At Home Services Market- Key Insights

• As per the analysis shared by our research analyst, the global Chemotherapy At Home Services market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2023-2030)

• Based on product type segmentation, Oral was predicted to show maximum market share in the year 2022

• Based on Cancer Type segmentation, Leukemia was the leading type in 2022

• On the basis of region, North America was the leading revenue generator in 2022

Chemotherapy At Home Services Market- Segmentation Analysis:

The Global Chemotherapy At Home Services Market is segmented on the basis of Product Type, Cancer Type and Region.

The market is divided into three categories based on product type: Oral and Infusion. The market is primarily dominated by the oral segment. Oral chemotherapy drugs are available in the form of pills or capsules, enabling patients to conveniently take them at home. This provides them with increased flexibility and the option of self-administration. Oncologists usually prescribe oral chemotherapy, and patients can conveniently obtain their medications from pharmacies. Certain pharmacies even provide specialized services for dispensing oral chemotherapy.

The market is divided into two categories based on Cancer Type: Breast Cancer, Colon Cancer, Rectum Cancer, Cervix Uteri Cancer, Lung Cancer, Prostate Cancer, Ovarian Cancer and Leukemia. Leukemia segment dominates the market. The market is predominantly controlled by the leukemia segment. Leukemia is classified into two main forms, namely acute and chronic, and further divided into myeloid and lymphoid types. The treatment methods employed depend on the precise type and subtype of leukemia. Chemotherapy is a common treatment modality for leukemia, particularly for acute forms. It involves the use of drugs to kill or control the growth of leukemia cells.

Chemotherapy At Home Services Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market in North America is expected to dominate the growth, primarily driven by the increasing demand for home infusion services for cancer treatment. In the event of a rise in cancer incidence in North America, there would likely be a surge in the demand for cancer treatment services, such as chemotherapy. This growing demand could lead to a need for more convenient and patient-friendly options like home-based services. It is estimated that approximately 1.7 million Americans are diagnosed with cancer each year. Within a year of diagnosis, three-quarters of those with advanced cancer end up being hospitalized, with 1 in 6 individuals being hospitalized three or more times. Additionally, almost everyone requiring chemotherapy spends several hours a day in physician offices or outpatient clinics, as reported by the frontiers of health and medicine. Europe holds the second-largest region for market growth during the forecast period, owing to the increasing demand for home-based chemotherapy services.

Chemotherapy At Home Services Market- Competitive Landscape:

While hospitals continue to be the primary location for pediatric cancer care, there is a growing trend towards providing care in the home setting. To ensure that comprehensive and appropriate care is delivered to children in their homes, it is crucial to consider the perspectives of key informants. Countries such as Canada, the United States, Australia, and Europe are expanding their home care services and treatments for children, including intravenous chemotherapy, post-chemotherapy hydration, monitoring of low-risk febrile neutropenia, and medication infusions. Manufacturers are actively seeking input from children, family caregivers, and clinicians to improve home-based cancer care services. This includes identifying the benefits and challenges associated with receiving or providing care at home, as well as making necessary modifications to enhance program acceptability and perceived usefulness. Pharmaceutical companies are collaborating with home healthcare providers to offer support services and resources for patients undergoing chemotherapy at home. These collaborations aim to improve patient education and adherence to treatment plans. In addition to national providers, local and regional home healthcare agencies may also offer at-home chemotherapy services in partnership with oncologists and hospitals, thereby extending cancer care to patients' homes.

Recent Developments:

In July 2023, a strategic alliance was formed between DispatchHealth and Reimagine Care to facilitate at-home cancer treatment. The collaboration lowers emergency room visits and unanticipated hospital stays.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET KEY PLAYERS

• Portea Medical
• Ubiqare
• Penn Medicine (The Trustees of the University of Pennsylvania)
• Advocate Health Care
• View Health Pty Ltd group (chemo@home Pty Ltd)
• Vitalis Health and Home Care Pty Ltd
• Medibank Private Limited
• TCP Homecare
• LloydsPharmacy Clinical Homecare

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY PRODUCT TYPE

• Oral
• Infusion

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY CANCER TYPE

• Breast Cancer
• Colon Cancer
• Rectum Cancer
• Cervix Uteri Cancer
• Lung Cancer
• Prostate Cancer
• Ovarian Cancer
• Leukemia

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Chemotherapy At Home Services Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Chemotherapy At Home Services Market Snippet by Product Type
  • 2.1.2. Chemotherapy At Home Services Market Snippet by Cancer Type
  • 2.1.3. Chemotherapy At Home Services Market Snippet by Country
  • 2.1.4. Chemotherapy At Home Services Market Snippet by Region
• 2.2. Competitive Insights

3. Chemotherapy At Home Services Key Market Trends

• 3.1. Chemotherapy At Home Services Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Chemotherapy At Home Services Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Chemotherapy At Home Services Market Opportunities
• 3.4. Chemotherapy At Home Services Market Future Trends

4. Chemotherapy At Home Services Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Chemotherapy At Home Services Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Chemotherapy At Home Services Market Landscape

• 6.1. Chemotherapy At Home Services Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Chemotherapy At Home Services Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
  • 7.1.2. Oral
  • 7.1.3. Infusion

8. Chemotherapy At Home Services Market - By Cancer Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Cancer Type, 2022 & 2030 (%)
  • 8.1.2. Breast Cancer
  • 8.1.3. Colon Cancer
  • 8.1.4. Rectum Cancer
  • 8.1.5. Cervix Uteri Cancer
  • 8.1.6. Lung Cancer
  • 8.1.7. Prostate Cancer
  • 8.1.8. Ovarian Cancer
  • 8.1.9. Leukemia

9. Chemotherapy At Home Services Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Chemotherapy At Home Services Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Chemotherapy At Home Services Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Chemotherapy At Home Services Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Chemotherapy At Home Services Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Chemotherapy At Home Services Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Chemotherapy At Home Services Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Sciensus Pharma Services Limited
  • 10.2.2. Portea Medical
  • 10.2.3. Ubiqare
  • 10.2.4. Penn Medicine (The Trustees of the University of Pennsylvania)
  • 10.2.5. Advocate Health Care
  • 10.2.6. View Health Pty Ltd group (chemo@home Pty Ltd)
  • 10.2.7. Vitalis Health and Home Care Pty Ltd
  • 10.2.8. Medibank Private Limited
  • 10.2.9. TCP Homecare
  • 10.2.10. LloydsPharmacy Clinical Homecare

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us